T wave abnormalities, high body mass index, current smoking and high lipoprotein (a) levels predict the development of major abnormal Q/QS patterns 20 years later. A population-based study by unknown
BioMed CentralBMC Cardiovascular Disorders
ssOpen AcceResearch article
T wave abnormalities, high body mass index, current smoking and 
high lipoprotein (a) levels predict the development of major 
abnormal Q/QS patterns 20 years later. A population-based study
Christina Strom Moller*†1,3, Liisa Byberg†1, Johan Sundstrom1 and 
Lars Lind2,3
Address: 1Department of Public Health and Caring Sciences/Geriatrics, Uppsala University, Sweden, 2Department of Medical Science, Uppsala 
University, Sweden and 3AstraZeneca, Research and Development, Sweden
Email: Christina Strom Moller* - Christina.Strom_moller@pubcare.uu.se; Liisa Byberg - liisa.byberg@pubcare.uu.se; 
Johan Sundstrom - johan.sundstrom@pubcare.uu.se; Lars Lind - lars.lind@medsci.uu.se
* Corresponding author    †Equal contributors
Abstract
Background: Most studies on risk factors for development of coronary heart disease (CHD) have
been based on the clinical outcome of CHD. Our aim was to identify factors that could predict the
development of ECG markers of CHD, such as abnormal Q/QS patterns, ST segment depression
and T wave abnormalities, in 70-year-old men, irrespective of clinical outcome.
Methods: Predictors for development of different ECG abnormalities were identified in a
population-based study using stepwise logistic regression. Anthropometrical and metabolic factors,
ECG abnormalities and vital signs from a health survey of men at age 50 were related to ECG
abnormalities identified in the same cohort 20 years later.
Results: At the age of 70, 9% had developed a major abnormal Q/QS pattern, but 63% of these
subjects had not been previously hospitalized due to MI, while 57% with symptomatic MI between
age 50 and 70 had no major Q/QS pattern at age 70. T wave abnormalities (Odds ratio 3.11, 95%
CI 1.18–8.17), high lipoprotein (a) levels, high body mass index (BMI) and smoking were identified
as significant independent predictors for the development of abnormal major Q/QS patterns. T
wave abnormalities and high fasting glucose levels were significant independent predictors for the
development of ST segment depression without abnormal Q/QS pattern.
Conclusion: T wave abnormalities on resting ECG should be given special attention and
correlated with clinical information. Risk factors for major Q/QS patterns need not be the same as
traditional risk factors for clinically recognized CHD. High lipoprotein (a) levels may be a stronger
risk factor for silent myocardial infarction (MI) compared to clinically recognized MI.
Background
Several longitudinal studies have investigated the impact
of different ECG abnormalities on future development of
coronary heart disease (CHD) with morbidity, based on
episodes of chest pain or mortality as end-points [1],
excluding those with silent myocardial infarction (MI).
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versial [2,3] and it remains uncertain whether patients
with silent MI have unique characteristics that distinguish
them from those with recognized events [4]. In the
present population-based study with 20 years of follow-
up, our primary objective was to identify predictors for the
development of abnormal major Q/QS patterns as a
marker for MI, irrespective of chest pain, in order to
obtain a complementary picture to previous studies. Our
secondary objective was to investigate predictors for ST
segment depression and T wave abnormalities. Among
the possible predictors were anthropometrical and meta-
bolic factors, as well as ECG items and vital signs.
Methods
Study sample
The Uppsala Study of Adult Men (ULSAM) is a longitudi-
nal study based on all available 50-year-old men in Upp-
sala, Sweden, born between 1920 and 1924. They were
invited to a health survey aimed at identifying risk factors
for cardiovascular disease [5]. Of the invited subjects,
2,322 (82%) participated in 1970–1973. In 1991–1995,
eligible participants were invited for re-examination at age
70. Of these, 1,221 (73%) participated. Between the 2 sur-
veys, 219 had moved and 422 had died 128 due to acute
MI. All subjects gave informed consent, and the Ethics
Committee of Uppsala University approved the study.
Official hospital discharge register data was available.
In the present study, all subjects hospitalized due to acute
MI before the 50-year survey (n = 8) or with major Q wave
(n = 6) or left bundle branch block (LBBB) (n = 5) on ECG
at age 50, were excluded from further analyses, resulting
in a study population of 2303 men at age 50 of which
1131 men were re-investigated at age 70. Development of
ST segment depression and isolated T wave abnormality
on ECG at age 70 were investigated in subgroups of 1006
men (additional exclusion of men with Minnesota codes
4.1–4.2 at age 50) and 858 men (additional exclusion of
men with Minnesota codes 4.1–4.2 at age 50 and/or 70,
and 5.1–5.4 at age 50), respectively.
Investigations and laboratory methods
Investigations at age 50
These investigations have been described extensively else-
where [5]. 12-lead resting ECGs were recorded, including
standard leads I, II and III, unipolar leads aVR, aVL and
aVF and V1-6. Two experienced physicians at the Depart-
ment of Clinical Physiology classified the ECGs according
to the Minnesota classification system [6,7] (Table 1). The
Minnesota codes were assessed on 12-lead ECGs. ST
depression was not tabulated when found in less than a
majority of beats of the leads and when the baseline was
swinging widely. Flat or inverted T waves were accepted in
leads III, aVL and V1. Body mass index (BMI) was calcu-
lated as weight (in kg) divided by height (in meters)
squared. Blood pressure (BP) was measured in the recum-
bent position after a 10 minutes rest with a mercury
manometer (Kifa Ercameter, wall-model). Blood glucose
was measured by spectrophotometry using the glucose
oxidase method. The serum insulin was determined with
the Phadebas Insulin Test (Pharmacia AB, Uppsala, Swe-
den). Concentrations of serum low-density lipoprotein
(LDL)-cholesterol, high-density lipoproteine (HDL)-cho-
lesterol and apolipoprotein AI (apoA1) and apolipopro-
tein B (apoB) were performed on serum samples stored in
liquid nitrogen since sampling. ApoB were determined by
a two-site immunoradiometric assay and apoA1 by a com-
petitive radioimmunoassay. Coding of smoking habits
was based on interview reports.
Investigations at age 70
The cohort was reinvestigated 20 years later and a stand-
ard resting ECG was obtained and classified according to
the Minnesota code [6,7] by one experienced physician.
Table 1: Minnesota classification of ECGs
ECG abnormalities Minnesota Code Definition
Q or QS pattern 1.1 Q duration ≥ 0.04s in I, II, V2–V6.
Q duration ≥ 0.05s in both aVF and III.
QS pattern through V1–V4, V5 and V6.
QS pattern when R wave is present in adjacent precordial lead to the right V2–V6.
ST segment depression 4.1–4.2 4.1: ST-depression ≥ 1 mm in I, II, aVL, aVF, V1–V6.
4.2: ST depression 0.5–0.9 mm in I, II, aVL, aVF, V1–V6.
T wave items 5.1–5.4 5.1: T amplitude ≥ 5 mm in I, II V2–V6 when R amplitude ≥ 5 mm in aVL when QRS 
mainly upright in aVF.
5.2: T amplitude = -1 to -5 in I, II, V2–V6 when R amplitude ≥ 5 mm in aVL when QRS 
mainly upright in aVF.
5.3: T wave flat or small diphasic in I, II, V2–V6 when R amplitude ≥ in aVL when QRS 
mainly upright in aVF.
5.4: T amplitude positive and T/R amplitude radio <1/20 in any of leads I, aVL, V6: R 
wave amplitude must be ≥ 10.0 mm.Page 2 of 7
(page number not for citation purposes)
BMC Cardiovascular Disorders 2006, 6:10 http://www.biomedcentral.com/1471-2261/6/10ECG abnormalities
Our primary outcome, a finding of a major abnormal Q/
QS pattern was defined according to the Minnesota code
1.1 [6,7]. Minor abnormal Q/QS patterns that only ful-
filled the requirements of Minnesota code 1.2 or 1.3 were
not included as end-points reducing the possibility of
inclusion of abnormal Q/QS patterns of other aetiologies
than CHD. Our secondary end-points were ST segment
depression (Minnesota 4.1–4.2) and T wave abnormali-
ties (Minnesota 5.1–5.4).
Subjects with ECG abnormalities observed during the sur-
vey were not further assessed by a cardiologist or evalu-
ated further by other cardiac examinations as part of the
protocol.
Statistical analyses
The distribution of a continuous variable was tested for
normality using Shapiro Wilk's test. Skewed variables
were logarithmically transformed to reach normal distri-
bution. Univariate regression analyes were performed on
the list of candidate predictor variables at age 50, compar-
ing those with and without ECG abnormalities at age 70
using χ2 test or ANOVA. A p < 0.05 was considered statis-
tically significant. All candidate predictors with a univari-
ate p < 0.15 were evaluated for independent association in
a backward stepwise logistic regression model. Continu-
ous variables were standardized to one standard deviation
(SD) to determine the magnitude of the relationship to,
and the statistical significance of the predictors of each of
the defined outcomes in the regression analyses. The
robustness of the final model was checked by including
previously removed variables. As an additional analysis,
the same variables were tested in the same model but sub-
stituting the end point major Q/QS pattern by death due
to acute MI before the 70-year examination. The preva-
lence of T wave abnormalities at age 50 in the subjects
who died during the 20-year follow-up period was also
compared to those who survived using χ2 test.
Results
The prevalence of CHD disease-related ECG items in
ULSAM at ages 50 and 70 are shown in Table 2. In our
cohort, 9% (n = 102) developed a major abnormal Q/QS
pattern by the age of 70 but 63% (n = 64) of these subjects
had not been hospitalized due to MI. Among the 89 men
that had been hospitalized due to MI at any time-point
during the 20 years follow-up, 57% (n = 51) had no major
Q/QS pattern on ECG at the age of 70. The prevalence of
T wave abnormalities had increased more than three-fold
and the prevalence of ST segment depression had
increased more than six-fold.
Major abnormal Q/QS pattern
When subjects with a new major abnormal Q/QS pattern
at age 70 (n = 102) were compared with those who had
not developed such ECG changes during the follow-up
period (n = 1033), those with abnormal Q/QS pattern
had elevated levels of BMI, serum triglycerides, serum
cholesterol, Lp (a) and apoB at age 50 (Table 3). There was
no statistically significant difference between the groups
regarding some of the traditional risk factors for CHD
including smoking and SBP. There was a higher preva-
lence of T wave abnormalities and minor Q/QS waves in
the group with major abnormal Q/QS pattern (Table 4).
Independent risk factors for development of a new major
abnormal Q/QS pattern on the ECG at age 70 were high
Lp (a), high BMI, current smoking and T wave abnormal-
ities all contributing to an increased risk (Table 5). There
was more than a three-fold risk for men with a T wave
abnormality at age 50 to develop a new major abnormal
Q/QS pattern at age 70 compared to men without T wave
abnormalities.
ST segment depression
Of the 1006 men free of ST segment depression at age 50,
13% had developed ST segment depression at the age of
70. In multiple logistic regression analysis T wave abnor-
malities (OR = 3.94, 95% CI 1.58–9.82, p = 0.003) and
high fasting blood glucose levels (OR = 1.25, 95% CI
Table 2: Prevalence of ECG abnormalities at age 50 and 70
ECG abnormalities * Age 50 (n = 2314) n (%) Age 70 (n = 1135) n (%)
Major Q or QS pattern (1.1) 6 (0.26) 102 (9.0)
Minor Q or QS pattern (1.2/1.3) 20 (0.86) 49 (4.32)
ST seg. depression (4.1/4.2) 50 (2.16) 161 (14.19)
T wave items (5.1–5.4) 130 (5.62) 180 (15.86)
LBBB (7.1) 5 (0.22) 18 (1.59)
High R-amplitude (3.1–3.3) 336 (14.52) 269 (26.8)
Atrial fibrillation/flutter (8.3) 7 (0.30) 55 (4.85)
* Minnesota codes in parenthesis.
LBBB, left bundle branch block
No attempt was made to eliminate overlap due to the occurrence of several items in one ECG. Subjects with acute MI before first survey were 
excluded from the analysis.Page 3 of 7
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segment depression.
Isolated T wave abnormality
Of the 858 men without ST segment depression (at age 50
and/or 70) and T wave abnormality at age 50, 9% had
developed an isolated T wave abnormality at the age of
70. An increase in BMI by 1SD increased the risk of having
a T wave abnormality at the age of 70 by 50% (OR = 1.48,
95% CI 1.14–1.92). None of the other variables tested
predicted future development of a T wave abnormality.
Subjects who died due to MI during the observation
period also had a significantly higher prevalence of T-
wave abnormalities at age 50 compared to those who sur-
vived (15.3% vs 4.8%, p < 0.01).
Death due acute MI
Independent risk factors at age 50 for death due to acute
MI before the 70-year examination were high BMI, high
DBP, high ApoB/ApoA1 ratio, T wave abnormalities,
smoking and diabetes mellitus (Table 6).
Discussion
Besides the presence of T wave abnormalities, we identi-
fied high BMI, high Lp (a) and smoking at age 50 as inde-
pendent risk factors for the development of major
abnormal Q/QS patterns at age 70. T wave abnormalities,
together with high fasting blood glucose were also impor-
tant predictors for the development of ST segment depres-
sion while participants with higher BMI had an increased
risk of developing T wave abnormalities.
This is a longitudinal community based study, with long
follow-up period, where all subjects from one birth cohort
in the community were invited to participate. The same
two nurses registered the ECGs at both surveys, contribut-
ing to consistency in electrode placement. Three physi-
cians carried out the coding of all ECGs, whereby the
coding consistency can be expected to be high. However,
coding errors may confound analysis of ECG data. An
obvious limitation of our study is that women were not
included. There was no validation of the outcome detec-
tion system, however, the myocardial infarction diagnosis
Table 3: Clinical characteristics at age 50 according to Q-QS pattern at age 70 (mean ± SD)
Variables, age 50 Abnormal Q-QS 
pattern (1.1) at age 70
n No abnormal Q-QS 
(1.1) pattern at age 70
n p value
BMI (kg/m2) 25.6 (3.2) 101 24.7 (2.9) 1030 0.003
SBP supine (mmHg) 134.4 (16.8) 101 131.3 (16.7) 1030 0.08
DBP supine (mmHg) 84.3 (11.4) 101 82.5 (10.4) 1030 0.1
Fasting B-gluc (mmol/l) 5.1 (1.1) 101 4.9 (0.6) 1029 0.2
Fasting insulin (μU/ml) 12.4 (7.9) 73 12.3 (6.5) 850 0.9
Serum TG (mmol/l) 2.0 (1.0) 101 1.8(0.9) 1030 0.04
Serum CHOL (mmol/l) 7.0 (1.1) 101 6.8 (1.3) 1030 0.06
HDL CHOL (mmol/l) 1.3 (0.3) 72 1.4 (0.4) 844 0.2
LDL CHOL (mmol/l) 5.4 (1.2) 72 5.2 (1.2) 844 0.2
Lp (a) (U/l) 322.2 (385.6) 72 234.8 (295.8) 815 0.01
ApoA1 (g/l) 1.4 (0.2) 76 1.4 (0.2) 817 0.7
ApoB (g/l) 1.3 (0.2) 76 1.2 (0.3) 817 0.03
ApoB/ApoA1 ratio 0.91 (0.2) 76 0.86 (0.2) 817 0.1
Smoking (%) 53 (52.5) 101 446 (43.3) 1030 0.08
BMI, Body Mass Index; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; CHOL, cholesterol; HDL, high-density 
lipoproteins; LDL, low-density lipoproteins; Lp(a), lipoprotein (a); ApoA1, apolipoprotein A1; ApoB, apolipoprotein B.
Table 4: ECG findings at age 50 according to Q-QS-pattern at age 70
ECG abnormalities* at age 50 Abnormal Q-QS pattern (1.1) 
at age 70 
(n = 102) n (%)
No abnormal Q-QS 
pattern (1.1) at age 70 
(n = 1033) n (%)
p value
Minor Q-QS pattern (1.2/1.3) 2 (2.0) 4 (0.4) 0.04
High amplitude R-wave (3.1/3.3) 11 (10.9) 148 (14.4) 0.3
ST-segment depression (4.1/4.2) 1 (1.0) 11 (1.0) 0.9
T-wave items (5.1–5.4) 8 (7.9) 31 (3.0) 0.01
AF/flutter (8.3) 0 (0) 3 (0.3) 0.6
* Minnesota codes in parenthesis
AF, atrial fibrillationPage 4 of 7
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rect in 93–97% of cases with less than one percent being
missed [8].
Our study is unique in that it uses ECG variables as out-
comes instead of clinical outcomes. By choosing major
abnormal Q/QS patterns as end-point, silent myocardial
infarctions have also been included in the analyses.
According to most studies a clinically unrecognized MI is
believed to be associated with the same risk as recognized
symptomatic MI [1,4,9] although a lower risk for unrecog-
nized MI has also been described [10]. The prevalence of
silent MI increases with age [1,2] and varies from 21% to
68% [2], with an average around 30% [11]. In our study,
63% of the subjects with a major abnormal Q/QS pattern
on ECG at the 70-year survey had not been previously
hospitalized due to MI. While the majority of major Q
waves are believed to be due to myocardial infarction,
some may be due to other causes, including myocarditis,
cardiac amyloidosis, and cardiomyopathy [12]. Also dis-
placement of the diaphragm and the heart, as in chronic
obstructive lung disease may cause the appearance of a
non-infarction Q wave and non-infarction Q waves may
be seen in subjects with pre-excitation syndrome and left
ventricular hypertrophy (LVH) [12]. The low specificity of
Q/QS pattern to recognize silent myocardial necrosis is an
additional limitation to our study.
Since some of the conventional risk factors [13] were not
strong predictors of the development of major abnormal
Q/QS patterns, our study suggests that predictors of major
abnormal Q/QS patterns may be different from those pre-
dicting symptomatic MI. This is further strengthened by
our additional analysis where the major Q/QS pattern
end-point was substituted by death due to acute MI before
the 70-year examination and where conventional risk fac-
tors such as diabetes mellitus and DBP became significant
predictors. Other authors have debated whether the pre-
disposing factors for silent MI are simply the traditional
risk factors for coronary atherosclerosis, or whether silent
MI patients have unique characteristics [4]. However, no
general conclusions can be drawn from our study since
our major abnormal Q/QS finding will include silent MI,
clinically recognized MI and some non-infarction Q
waves.
Loss of Q wave could explain some of the cases where
diagnosis of MI was not accompanied by a visible major
Q/QS pattern at age 70. Even though development of Q
waves after acute MI has been considered an indicator of
myocardial necrosis, studies have shown that Q wave loss
may occur in 11–20% of patients after transmural MI
[14,15]. The clinical significance of such an ECG phenom-
enon has not been fully clarified [16]. Functional recovery
of stunned and/or hibernating myocardium [16], as well
as regeneration of myocytes [17] has been proposed as
possible mechanisms.
The pathophysiologic basis of ST segment depression on
resting ECG remains speculative, and ST segment depres-
sion is seen both in left ventricular hypertrophy and myo-
cardial ischemia [1]. One of the possible etiologies for
development of left ventricular hypertrophy is altered glu-
cose metabolism with insulin resistance and hyperin-
Table 5: Multivariate logistic regression analysis for development of abnormal Q-QS pattern (Minnesota 1.1) on ECG at age 70
Variable Odds Ratio (95% - CI) p value
BMI (1SD = 3.3 kg/m2) 1.32 (1.03–1.68) 0.03
Lp (a) 1.35 (1.05–1.73) 0.02
T-wave abnormality* 3.11 (1.18–8.17) 0.02
Smoking 1.63 (1.01–2.65) 0.046
Odds ratios from logistic regression were applied to variables standardised to one standard deviation and adjusted for age at entry.
*Minnesota code 5.1–5.4
Table 6: Multivariate logistic regression analysis for death due to myocardial infarction before 70-year examination
Variable Odds Ratio (95% - CI) p value
BMI (1SD = 3.3 kg/m2) 1.29 (1.01–1.57) 0.009
DBP supine (mmHg) 1.66 (1.37–2.02) <0.001
ApoB/ApoA1 ratio 1.50 (1.23–1.83) <0.001
T-wave abnormality* 2.66 (1.45–4.89) 0.002
Smoking 1.81 (1.17–2.82) 0.008
Diabetes mellitus 2.05 (1.03–4.07) 0.03
Odds ratios from logistic regression were applied to variables standardised to one standard deviation and adjusted for age at entry.
*Minnesota code 5.1–5.4Page 5 of 7
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diabetes mellitus are known to have an increased risk of
developing arteriosclerosis [20], so an impaired glucose
metabolism could well be a predictor for ST segment
depression due to either left ventricular hypertrophy or
coronary heart disease.
While permanent negative T waves in the chronic stage of
MI have indicated the presence of transmural infarction
[21]. T waves in a post-myocardial phase have been
shown to be associated with the presence of viable myo-
cardium at jeopardy [22]. T waves should therefore be
regarded as a dynamic substrate. Even though subjects not
surviving the MI were not included in our main analyses,
we found that the prevalence of major T wave abnormali-
ties in those who died during the period due to acute MI
was statistically significantly higher for this group com-
pared to those who survived, suggesting that the predic-
tive power of T wave abnormalities is not restricted to
survivors of a Q wave MI.
High BMI predicted both major abnormal Q/QS pattern
and abnormal T wave. One possible mechanism is hori-
zontal displacement of the heart [23], but left ventricular
hypertrophy may also play a role.
Lp (a) is believed to have potential pathogenic effects on
atherosclerosis and thrombosis [24-26]. Some previous
studies have identified elevated Lp (a) as a risk factor lead-
ing to premature MI [27,28], while others have shown no
association between Lp (a) and risk for CHD [24]. One
study has, in diabetic patients, specifically found Lp(a) to
be associated with silent CHD [29]. Our study supports
the finding that Lp (a) may be important an important
predictor of CHD and silent MI.
The present approach using ECG-based diagnosis should
be regarded as a complement to the more traditional
approach used in most previous studies. One should
therefore be careful not to generalize the conclusion of
this study to other population groups, and further studies
for confirmation of our findings are motivated.
Conclusion
T wave abnormalities on ECG at age 50, was an independ-
ent risk factor for the development of major Q/QS abnor-
malities and ST segment depression on ECG at age 70. A
finding of a T wave abnormality on ECG should be given
special attention even though an isolated T wave change
should be interpreted with caution and correlated with all
available clinical and laboratory information. Risk factors
for major abnormal Q/QS patterns may not be the same
as risk factors for clinically recognized CHD and high Lp
(a) levels may be a stronger risk factor for silent myocar-
dial infarction (MI) compared to clinically recognized MI.
Re-measurement of ECG after MI may give information
on viability of myocardium through Q wave regression,
which may be more frequent than previously believed.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
CSM and LB participated in the design of the study and
performed the statistical analyses. CSM, LB and LL drafted
the manuscript.
All authors participated in the design of the study, read
and approved the final manuscript.
Acknowledgements
This work was funded by the Medical Faculty at Uppsala University, Royal 
Society of Science, Swedish Council for Planning and Co-ordination of 
Research, Swedish National Association against Heart and Lung Disease, 
Swedish Medical Research Council, and the Trygg Hansa Research Fund.
None of the funders have had any role in the study design; in the collection, 
analysis, and interpretation of data; in the writing of the manuscript; nor in 
the decision to submit the manuscript for publication.
References
1. Ashley EA, Raxwal VK, Froelicher VF: The prevalence and prog-
nostic significance of electrocardiographic abnormalities.
Curr Probl Cardiol 2000, 25:1-72.
2. Aronow WS: Silent MI. Prevalence and prognosis in older
patients diagnosed by routine electrocardiograms.  Geriatrics
2003, 58:24-6. 36–8, 40
3. Cohn PF, Fox KM, Daly C: Silent myocardial ischemia.  Circulation
2003, 108:1263-77.
4. Sheifer SE, Gersh BJ, Yanez ND 3rd, Ades PA, Burke GL, Manolio TA:
Prevalence, predisposing factors, and prognosis of clinically
unrecognized myocardial infarction in the elderly.  J Am Coll
Cardiol 2000, 35:119-26.
5. Hedstrand H: A study of middle-aged men with particular ref-
erence to risk factors for cardiovascular disease.  Ups J Med Sci
Suppl 1975, 19:1-61.
6. Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S: The elec-
trocardiogram in population studies. A classification system.
Circulation 1960, 21:1160-75.
7. Prineas R, Crow R, Blackburn H: The Minnesota Code Manual of
Electrocardiographic Findings, Standards and Procedures
for Measuring and Classification.  1982.
8. Lindblad U, Rastam L, Ranstam J, Peterson M: Validity of register
data on acute myocardial infarction and acute stroke: the
Skaraborg Hypertension Project.  Scand J Soc Med 1993, 21:3-9.
9. Kannel WB, Abbott RD: Incidence and prognosis of unrecog-
nized myocardial infarction. An update on the Framingham
study.  N Engl J Med 1984, 311:1144-7.
10. Medalie JH, Kahn HA, Neufeld HN, Riss E, Goldbourt U, Perlstein T,
Oron D: Myocardial infarction over a five-year period. I. Prev-
alence, incidence and mortality experience.  J Chronic Dis 1973,
26:63-84.
11. Nadelmann J, Frishman WH, Ooi WL, Tepper D, Greenberg S, Guzik
H, Lazar EJ, Heiman M, Aronson M: Prevalence, incidence and
prognosis of recognized and unrecognized myocardial inf-
arction in persons aged 75 years or older: The Bronx Aging
Study.  Am J Cardiol 1990, 66:533-7.
12. Fisch C: Heart Disease: A textbook of cardiovascular medi-
cine, Fifth Edition. Chapter 4.  Fifth1997.
13. Wilson PW: Established risk factors and coronary artery dis-
ease: the Framingham Study.  Am J Hypertens 1994, 7:7S-12S.Page 6 of 7
(page number not for citation purposes)
BMC Cardiovascular Disorders 2006, 6:10 http://www.biomedcentral.com/1471-2261/6/10Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
14. Coll S, Betriu A, de Flores T, Roig E, Sanz G, Mont L, Magrina J, Serra
A, Navarro Lopez F: Significance of Q-wave regression after
transmural acute myocardial infarction.  Am J Cardiol 1988,
61:739-42.
15. Lancellotti P, Gerard PL, Kulbertus HE, Pierard LA: Persistent neg-
ative T waves in the infarct-related leads as an independent
predictor of poor long-term prognosis after acute myocar-
dial infarction.  Am J Cardiol 2002, 90:833-7.
16. Voon WC, Chen YW, Hsu CC, Lai WT, Sheu SH: Q-wave regres-
sion after acute myocardial infarction assessed by Tl-201
myocardial perfusion SPECT.  J Nucl Cardiol 2004, 11:165-70.
17. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R,
Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, Anversa P: Evidence
that human cardiac myocytes divide after myocardial infarc-
tion.  N Engl J Med 2001, 344:1750-7.
18. Sundstrom J, Lind L, Nystrom N, Zethelius B, Andren B, Hales CN,
Lithell HO: Left ventricular concentric remodeling rather
than left ventricular hypertrophy is related to the insulin
resistance syndrome in elderly men.  Circulation 2000,
101:2595-600.
19. Felicio JS, Ferreira SR, Plavnik FL, Moises V, Kohlmann O Jr, Ribeiro
AB, Zanella MT: Effect of blood glucose on left ventricular
mass in patients with hypertension and type 2 diabetes mel-
litus.  Am J Hypertens 2000, 13:1149-54.
20. Koschinsky ML, Marcovina SM: The relationship between lipo-
protein(a) and the complications of diabetes mellitus.  Acta
Diabetol 2003, 40:65-76.
21. Maeda S, Imai T, Kuboki K, Chida K, Watanabe C, Ohkawa S: Path-
ologic implications of restored positive T waves and persist-
ent negative T waves after Q wave myocardial infarction.  J
Am Coll Cardiol 1996, 28:1514-8.
22. Pierard LA, Lancellotti P: Determinants of persistent negative T
waves and early versus late T wave normalisation after acute
myocardial infarction.  Heart 2005, 91:1008-12.
23. Alpert MA, Terry BE, Cohen MV, Fan TM, Painter JA, Massey CV:
The electrocardiogram in morbid obesity.  Am J Cardiol 2000,
85:908-10. A10
24. Marcovina SM, Koschinsky ML: Lipoprotein(a) as a risk factor for
coronary artery disease.  Am J Cardiol 1998, 82:57U-66U. discus-
sion 86U
25. Scott J: Lipoprotein(a). Thrombogenesis linked to atherogen-
esis at last?  Nature 1989, 341:22-3.
26. Scanu AM: Lipoprotein(a) and the Atherothrombotic Process:
Mechanistic Insights and Clinical Implications.  Curr Atheroscler
Rep 2003, 5:106-13.
27. Seed M, Ayres KL, Humphries SE, Miller GJ: Lipoprotein (a) as a
predictor of myocardial infarction in middle-aged men.  Am J
Med 2001, 110:22-7.
28. Danesh J, Collins R, Peto R: Lipoprotein(a) and coronary heart
disease. Meta-analysis of prospective studies.  Circulation 2000,
102:1082-5.
29. Gazzaruso C, Garzaniti A, Giordanetti S, Falcone C, Fratino P: Silent
coronary artery disease in type 2 diabetes mellitus: the role
of Lipoprotein(a), homocysteine and apo(a) polymorphism.
Cardiovasc Diabetol 2002, 1:5.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2261/6/10/prepubPage 7 of 7
(page number not for citation purposes)
